Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amides | 6 | 2023 | 68 | 3.130 |
Why?
|
| Carboxylic Ester Hydrolases | 7 | 2014 | 52 | 2.050 |
Why?
|
| Protein Prenylation | 4 | 2013 | 10 | 1.340 |
Why?
|
| Antineoplastic Agents | 4 | 2023 | 803 | 1.250 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 358 | 0.920 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2023 | 7 | 0.900 |
Why?
|
| Cell Movement | 4 | 2023 | 571 | 0.880 |
Why?
|
| Protein Methyltransferases | 3 | 2011 | 6 | 0.840 |
Why?
|
| S-Adenosylmethionine | 5 | 2004 | 38 | 0.700 |
Why?
|
| Cell Proliferation | 3 | 2023 | 1198 | 0.670 |
Why?
|
| Peptidyl-Dipeptidase A | 7 | 2006 | 31 | 0.660 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 48 | 0.650 |
Why?
|
| Chorioallantoic Membrane | 1 | 2016 | 11 | 0.580 |
Why?
|
| Cell Survival | 6 | 2021 | 864 | 0.570 |
Why?
|
| Houseflies | 6 | 1997 | 6 | 0.570 |
Why?
|
| Actins | 1 | 2017 | 148 | 0.560 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 59 | 0.560 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 59 | 0.550 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 73 | 0.540 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 88 | 0.540 |
Why?
|
| Cell Line, Tumor | 6 | 2023 | 2231 | 0.500 |
Why?
|
| Neoplasms | 2 | 2023 | 1103 | 0.480 |
Why?
|
| Apoptosis | 3 | 2019 | 1398 | 0.480 |
Why?
|
| Mutation | 2 | 2019 | 1095 | 0.470 |
Why?
|
| Liver | 2 | 2008 | 479 | 0.450 |
Why?
|
| Curcumin | 1 | 2013 | 74 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 111 | 0.420 |
Why?
|
| Subtilisins | 5 | 1999 | 9 | 0.420 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2012 | 5 | 0.420 |
Why?
|
| Benzopyrans | 1 | 2012 | 14 | 0.420 |
Why?
|
| Carboxylesterase | 2 | 2011 | 4 | 0.420 |
Why?
|
| Sus scrofa | 2 | 2011 | 19 | 0.410 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1502 | 0.410 |
Why?
|
| Sulfinic Acids | 1 | 2011 | 4 | 0.400 |
Why?
|
| Hydrolysis | 9 | 2011 | 99 | 0.380 |
Why?
|
| Animals | 30 | 2016 | 15081 | 0.370 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 433 | 0.360 |
Why?
|
| Methylation | 6 | 2012 | 113 | 0.330 |
Why?
|
| Spheroids, Cellular | 2 | 2019 | 28 | 0.310 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 441 | 0.310 |
Why?
|
| Humans | 16 | 2023 | 37093 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 6 | 2004 | 360 | 0.300 |
Why?
|
| Haloperidol | 2 | 2019 | 26 | 0.290 |
Why?
|
| Kinetics | 7 | 2013 | 708 | 0.280 |
Why?
|
| Substrate Specificity | 6 | 2011 | 212 | 0.270 |
Why?
|
| Structure-Activity Relationship | 6 | 2019 | 409 | 0.260 |
Why?
|
| Pituitary Hormones | 4 | 1999 | 7 | 0.250 |
Why?
|
| Cysteine | 2 | 2008 | 98 | 0.250 |
Why?
|
| Neuropeptides | 2 | 1997 | 59 | 0.250 |
Why?
|
| Rats | 14 | 2014 | 3483 | 0.250 |
Why?
|
| Organophosphorus Compounds | 1 | 2005 | 37 | 0.250 |
Why?
|
| Amino Acid Sequence | 10 | 2008 | 1180 | 0.250 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2014 | 73 | 0.250 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2003 | 8 | 0.240 |
Why?
|
| Cystine | 1 | 2003 | 14 | 0.230 |
Why?
|
| Parkinsonian Disorders | 2 | 2002 | 37 | 0.230 |
Why?
|
| Tremor | 2 | 2000 | 9 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2014 | 1618 | 0.210 |
Why?
|
| Molecular Sequence Data | 9 | 2008 | 1568 | 0.210 |
Why?
|
| Dopamine Antagonists | 3 | 2014 | 44 | 0.190 |
Why?
|
| Swine | 2 | 2012 | 184 | 0.190 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2000 | 10 | 0.190 |
Why?
|
| Lung | 1 | 2023 | 446 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 4 | 1999 | 173 | 0.180 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 14 | 0.170 |
Why?
|
| Receptors, sigma | 1 | 2019 | 15 | 0.170 |
Why?
|
| Azepines | 1 | 2019 | 17 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 1039 | 0.170 |
Why?
|
| Hemolymph | 2 | 1997 | 8 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2019 | 113 | 0.160 |
Why?
|
| Pseudopodia | 1 | 2017 | 15 | 0.150 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 30 | 0.150 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 23 | 0.150 |
Why?
|
| Pentanes | 1 | 2016 | 5 | 0.140 |
Why?
|
| Hemiterpenes | 1 | 2016 | 7 | 0.140 |
Why?
|
| Butadienes | 1 | 2016 | 29 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 222 | 0.140 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 46 | 0.140 |
Why?
|
| Chick Embryo | 1 | 2016 | 74 | 0.140 |
Why?
|
| Chromatography, Gel | 3 | 2005 | 50 | 0.140 |
Why?
|
| Protein Binding | 3 | 2017 | 972 | 0.140 |
Why?
|
| Sodium Chloride | 1 | 1996 | 55 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2016 | 1518 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 502 | 0.140 |
Why?
|
| Endopeptidases | 1 | 1996 | 59 | 0.130 |
Why?
|
| Molecular Structure | 2 | 2014 | 492 | 0.130 |
Why?
|
| Polymers | 1 | 2016 | 121 | 0.130 |
Why?
|
| Zebrafish | 1 | 2016 | 128 | 0.130 |
Why?
|
| Brain | 5 | 2005 | 1346 | 0.130 |
Why?
|
| Cell Death | 2 | 2014 | 267 | 0.130 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2014 | 15 | 0.130 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2014 | 15 | 0.130 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 30 | 0.130 |
Why?
|
| Neurites | 1 | 2014 | 39 | 0.120 |
Why?
|
| CHO Cells | 5 | 2014 | 124 | 0.120 |
Why?
|
| Manduca | 1 | 1994 | 9 | 0.120 |
Why?
|
| Tropanes | 1 | 2014 | 6 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 1371 | 0.120 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1994 | 1 | 0.120 |
Why?
|
| Cricetinae | 5 | 2014 | 238 | 0.120 |
Why?
|
| Acrylamides | 1 | 2014 | 8 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 14 | 0.120 |
Why?
|
| Oxidopamine | 2 | 2006 | 20 | 0.120 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 68 | 0.120 |
Why?
|
| Metalloendopeptidases | 1 | 1993 | 16 | 0.120 |
Why?
|
| Microtubules | 1 | 2014 | 120 | 0.120 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 52 | 0.110 |
Why?
|
| Protein Precursors | 3 | 1998 | 61 | 0.110 |
Why?
|
| Indoles | 1 | 2014 | 158 | 0.110 |
Why?
|
| Perfume | 1 | 2012 | 3 | 0.110 |
Why?
|
| Amphetamine | 2 | 2003 | 16 | 0.110 |
Why?
|
| Proprotein Convertase 2 | 5 | 1999 | 21 | 0.100 |
Why?
|
| Edetic Acid | 3 | 1999 | 23 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2021 | 1908 | 0.100 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 2011 | 3 | 0.100 |
Why?
|
| Behavior, Animal | 2 | 2006 | 314 | 0.100 |
Why?
|
| Catalytic Domain | 1 | 2011 | 109 | 0.100 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 4 | 1999 | 5 | 0.100 |
Why?
|
| Catalysis | 1 | 2011 | 179 | 0.090 |
Why?
|
| Enzyme Activation | 4 | 2006 | 444 | 0.090 |
Why?
|
| Neurons | 3 | 2014 | 1175 | 0.090 |
Why?
|
| Models, Molecular | 1 | 2014 | 808 | 0.090 |
Why?
|
| Recombinant Proteins | 5 | 1999 | 515 | 0.090 |
Why?
|
| Oligopeptides | 3 | 1996 | 102 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 2 | 2003 | 174 | 0.090 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2008 | 9 | 0.090 |
Why?
|
| Peptides | 3 | 1997 | 320 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2010 | 389 | 0.080 |
Why?
|
| Molecular Weight | 3 | 1999 | 167 | 0.080 |
Why?
|
| Dopamine | 3 | 2006 | 245 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2006 | 69 | 0.080 |
Why?
|
| Esters | 1 | 2008 | 28 | 0.080 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 50 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 807 | 0.080 |
Why?
|
| Enkephalins | 2 | 1998 | 33 | 0.080 |
Why?
|
| Motor Activity | 3 | 2014 | 418 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 201 | 0.080 |
Why?
|
| Insect Hormones | 3 | 1997 | 8 | 0.080 |
Why?
|
| Male | 8 | 2006 | 20025 | 0.070 |
Why?
|
| Cathepsin D | 1 | 2006 | 17 | 0.070 |
Why?
|
| Juvenile Hormones | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cystatins | 1 | 2006 | 19 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2006 | 177 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 59 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 260 | 0.070 |
Why?
|
| MPTP Poisoning | 1 | 2006 | 11 | 0.070 |
Why?
|
| Paraquat | 1 | 2006 | 21 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2006 | 57 | 0.070 |
Why?
|
| Ligands | 2 | 2019 | 349 | 0.070 |
Why?
|
| Drug Design | 1 | 2006 | 162 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1999 | 364 | 0.060 |
Why?
|
| PC12 Cells | 3 | 2014 | 93 | 0.060 |
Why?
|
| Female | 2 | 2023 | 20969 | 0.060 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 22 | 0.060 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 2 | 1994 | 6 | 0.060 |
Why?
|
| Cations, Divalent | 2 | 1994 | 24 | 0.060 |
Why?
|
| Temperature | 2 | 1996 | 286 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 132 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2003 | 7 | 0.060 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 25 | 0.060 |
Why?
|
| Body Temperature | 1 | 2003 | 36 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 95 | 0.060 |
Why?
|
| Culture Media, Conditioned | 2 | 2002 | 46 | 0.060 |
Why?
|
| Triazoles | 1 | 2003 | 86 | 0.050 |
Why?
|
| Methionine | 1 | 2002 | 30 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 211 | 0.050 |
Why?
|
| Mice | 5 | 2014 | 5913 | 0.050 |
Why?
|
| California | 1 | 2023 | 476 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 410 | 0.050 |
Why?
|
| Sympathectomy, Chemical | 1 | 2000 | 1 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2006 | 938 | 0.050 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 22 | 0.050 |
Why?
|
| Freeze Drying | 1 | 2000 | 27 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2014 | 111 | 0.040 |
Why?
|
| Enzyme Stability | 2 | 1996 | 35 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 1999 | 308 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1999 | 26 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 587 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 1999 | 49 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 1996 | 119 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 72 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2004 | 381 | 0.040 |
Why?
|
| Transfection | 1 | 1999 | 523 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.040 |
Why?
|
| Mammals | 2 | 1997 | 105 | 0.040 |
Why?
|
| Base Sequence | 2 | 1996 | 997 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 1997 | 40 | 0.040 |
Why?
|
| Insect Proteins | 1 | 1997 | 50 | 0.040 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1996 | 33 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 183 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1996 | 67 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 480 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 286 | 0.030 |
Why?
|
| Binding Sites | 2 | 1996 | 651 | 0.030 |
Why?
|
| Time Factors | 1 | 2000 | 1742 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2014 | 6 | 0.030 |
Why?
|
| Catalepsy | 1 | 2014 | 8 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1997 | 421 | 0.030 |
Why?
|
| Cerebellum | 1 | 2014 | 73 | 0.030 |
Why?
|
| Apomorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2006 | 78 | 0.030 |
Why?
|
| Octoxynol | 1 | 1994 | 19 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2014 | 6 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 58 | 0.030 |
Why?
|
| Detergents | 1 | 1994 | 24 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 88 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 80 | 0.030 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 1993 | 7 | 0.030 |
Why?
|
| Species Specificity | 1 | 1994 | 245 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1994 | 84 | 0.030 |
Why?
|
| Membranes | 1 | 1993 | 19 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 1995 | 180 | 0.030 |
Why?
|
| Hippocampus | 1 | 2014 | 561 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2006 | 14 | 0.020 |
Why?
|
| Cystatin C | 1 | 2006 | 24 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2006 | 26 | 0.020 |
Why?
|
| Reproduction | 1 | 2006 | 71 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 13 | 0.020 |
Why?
|
| Lysosomes | 1 | 2006 | 91 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2006 | 27 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 207 | 0.020 |
Why?
|
| Herbicides | 1 | 2006 | 44 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2006 | 178 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 435 | 0.020 |
Why?
|
| Mazindol | 1 | 2004 | 4 | 0.020 |
Why?
|
| Tritium | 1 | 2004 | 51 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2004 | 66 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 64 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 48 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 50 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 245 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2004 | 40 | 0.010 |
Why?
|
| Benzazepines | 1 | 2004 | 32 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 99 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2004 | 140 | 0.010 |
Why?
|
| Phospholipids | 1 | 2004 | 70 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 207 | 0.010 |
Why?
|
| Benzamides | 1 | 2004 | 78 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 644 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2004 | 77 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2004 | 104 | 0.010 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2002 | 9 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 550 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 77 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 62 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 92 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1609 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 239 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 369 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1996 | 43 | 0.010 |
Why?
|
| Proinsulin | 1 | 1996 | 1 | 0.010 |
Why?
|
| Proline | 1 | 1996 | 43 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 1998 | 933 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 325 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 1354 | 0.010 |
Why?
|